GHRH analog is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-04-08. Numbers and descriptions here follow the published literature rather than marketing material.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.
Tesamorelin is a synthetic analog of growth hormone-releasing hormone, a peptide hormone produced by the hypothalamus. The molecule retains the 44-amino-acid sequence of human GHRH and carries a trans-3-hexenoyl modification at its N-terminus. This modification increases resistance to enzymatic degradation and extends the peptide's functional stability relative to native GHRH. The compound is supplied as a lyophilized powder for reconstitution and subcutaneous administration in clinical settings. Its development code was TH9507, and it belongs to the GHRH analog class. It is not a growth hormone product; instead, it acts upstream to stimulate endogenous growth hormone release.
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
She added that the clitoris "extends away from the body in a sleek and slender arc, measuring, on average, over 17 cm from root to tip. Just like a penis, [it] is fully erectile, raising its head in hyena greeting ceremonies, social displays, games of rough and tumble or when sniffing out peers".
=== Multiplexed DIA (plexDIA) === The progress in data independent acquisition (DIA) enabled multiplexed quantitative proteomics with non-isobaric mass tags and a new method called plexDIA introduced in 2021. This new approach increases the number of data points by parallelizing both samples and peptides, thus achieving multiplicative gains. It has the potential to continue scaling proteomic throughput with new mass tags and algorithms. plexDIA is applicable to both bulk and single-cell samples and is particularly powerful for single-cell proteomics.
Some researchers have noted that science, limited in that age to some early ideas about astronomy (or cosmology), had limited impact on Paleolithic technology. Making fire was widespread knowledge, and it was possible without an understanding of chemical processes. These types of practical skills are sometimes called crafts. Religion, superstitution or appeals to the supernatural may have played a part in the cultural explanations of phenomena like combustion.
The British Phosphate Commissioners (BPC) was a board of Australian, British, and New Zealand representatives who managed extraction of phosphate from Christmas Island, Nauru, and Banaba (Ocean Island) from 1920 until 1981. Nauru was a mandate territory governed on behalf of Nauru by Australia, Britain and New Zealand. However, representatives on the Permanent Mandates Commission argued that the activities of the BPC on Nauru were exploitative and not to the benefit of Nauruans. Australia intentionally suppressed information about its activities in Nauru. In 1968, Nauru brought Australia up before the International Court of Justice over the environmental devastation that they had caused on Nauru.
Sources: en.wikipedia.org
=== As biochemical reactors === Synthetic condensates offer a way to probe cellular function and organization with high spatial and temporal control, but can also be used to modify or add functionality to the cell. One way this is accomplished is by modifying the condensate networks to include binding sites for other proteins of interest, thus allowing the condensate to serve as a scaffold for protein release or recruitment. These binding sites can be modified to be sensitive to light activation or small molecule addition, thus giving temporal control over the recruitment of a specific protein of interest. By recruiting specific proteins to condensates, reactants can be concentrated to increase reaction rates or sequestered to inhibit reactivity. More importantly, by spatially organizing the proximity of enzymes in a complex pathway, synthetic condensates can be used to direct the metabolic flux of branched reactions. In an extreme example of using RNA-based synthetic organelle TEARS to organize violacine biosynthesis pathway in E. coli, the side reaction that produces deoxychromoviridans over the desired product deoxyviolacine can be abolished completely by TEARs. In addition to protein recruitment, condensates can also be designed which release proteins in response to certain stimuli. In this case, a protein of interest can be fused to a scaffold protein via a photocleavable linker. Upon irradiation, the linker is broken, and the protein is released from the condensate.
=== 1990 === 5 August The Nuts and Bolts of Ben Bowlby, 23 year old Ben Bowlby; his sister Sophie studied costume design; his father was a photographer at the Royal Free Hospital; the first fifteen minutes would be shown as part of the November 1991 episode; monocoque structures; his child psychiatrist grandfather John Bowlby, the son of Sir Anthony Bowlby; Frank Dernie at Team Lotus in Norfolk, and automotive diffusers; circuits at Snetterton Circuit. Narrated by Martin Jarvis, directed by Patrick Uden, made by Uden Associates 12 August The Greenhouse Conspiracy 19 August Selling the Secret, about the Soviet Union selling technology; it visited the Khrunichev State Research and Production Space Center in Moscow. Produced by Paul Murricane, directed by Ross Wilson, made by Scottish Television 2 September Blue Skies, about British innovation and its funding; biologist Nigel R.
Chem. Int. Ed. 2017, 56, 16018-16022. https://doi.org/10.1002/anie.201709463. M, Hifsudheen.; R, K, Mishra.; B, Vedhanarayanan.; V, K, Praveen.; and Ajayaghosh, Ayyappanpillai (2017). “Helix to Super-Helix Transition in p-Systems Self-assembly: Superseding of Molecular Chirality at Hierarchical Level”. Angew. Chem., Int. Ed. 2017, 56, 12634-12638. https://doi.org/10.1002/anie.201707392. S, Ghosh.; S, Cherumukkil.; C, H, Suresh.; and Ajayaghosh, Ayyappanpillai (2017). “A Supramolecular Nanocomposite as Near Infrared Transmitting Optical Filter for Security and Forensic Applications”. Adv. Mater. 2017, 29, 1703783.doi:10.1002/adma.201703783 A, Mal.; R, K, Mishra.; V, K, Praveen.; M, A, Khayum.; R, Banerjee.; and Ajayaghosh, Ayyappanpillai (2018). “Supramolecular Reassembly of Self-Exfoliated Ionic Covalent Organic Nanosheets for Label-Free Detection of dsDNA”. Angew. Chem., Int. Ed. 2018, 57, 8443. https://doi.org/10.1002/anie.201801352. R, D, Mukhopadhyay.; G, Das.; and Ajayaghosh, Ayyappanpillai (2018). “Stepwise Control of Host-Guest Interaction Using a Coordination Polymer Gel”. Nat. Commun. 2018, 9, 1987. https://doi.org/10.1038/s41467-018-04303-8. V, K, Praveen.; B, Vedhanarayanan.; A, Mal.; R, K, Mishra.; and Ajayaghosh Ayyappanpillai (2020). “Self-Assembled Extended p‑Systems for Sensing and Security Applications”. Acc. Chem. Res. 2020, 53, 2, 496-507. https://doi.org/10.1021/acs.accounts.9b00580 S, Chakraborty.; M, M, Joseph.; S, Varughese.; S, Ghosh.; K, K, Maiti.; A, Samanta.; and Ajayaghosh, Ayyappanpillai (2020).
The idea that large amounts of intravenous ascorbic acid can improve outcomes of late-stage cancer or ameliorate the toxicity of chemotherapy is—some forty years after Pauling's seminal paper—still considered unproven and still in need of high quality research.
=== Versus TCAs === There appears to be no significant difference in effectiveness between SSRIs and tricyclic antidepressants, which were the most commonly used class of antidepressants before the development of SSRIs. However, SSRIs have the important advantage that their toxic dose is high, and, therefore, they are much more difficult to use as a means to commit suicide. Further, they have fewer and milder side effects. Tricyclic antidepressants also have a higher risk of serious cardiovascular side effects, which SSRIs lack. SSRIs act on signal pathways such as cyclic adenosine monophosphate (cAMP) on the postsynaptic neuronal cell, which leads to the release of brain-derived neurotrophic factor (BDNF). BDNF enhances the growth and survival of cortical neurons and synapses.
Sources: en.wikipedia.org
== Side effects == The US prescribing information for datopotamab deruxtecan includes warnings and precautions for interstitial lung disease/pneumonitis, ocular adverse reactions, stomatitis/oral mucositis, and embryo-fetal toxicity. Datopotamab deruxtecan is associated with a range of adverse events. The most common side effects are stomatitis, nausea, fatigue, alopecia (hair loss), constipation, vomiting, dry eye, keratitis, anemia, decreased appetite, increased aspartate transferase (AST), rash, diarrhea, neutropenia, and increased alanine aminotransferase (ALT).
SLC is the root name (SoLute Carrier) n = an integer representing a family (e.g., 1-52) X = a single letter (A, B, C, ...) denoting a subfamily m = an integer representing an individual family member (isoform). For example, SLC1A1 is the first isoform of subfamily A of SLC family 1. An exception occurs with SLC family 21 (the organic anion transporting polypeptide transporters), which for historical reasons have names in the format SLCOnXm where n = family number, X = subfamily letter, and m = member number. While the HGNC only assign nomenclature to human genes, by convention vertebrate orthologs of these genes adopt the same nomenclature (e.g., VGNC-assigned orthologs of SLC10A1). For rodents, the case of the symbols differs from other vertebrates by using title case, i.e. Slc1a1 denotes the rodent ortholog of the human SLC1A1 gene.
The difference between the 1971 model and the eventual Il-86 was in configuration: the model had looked like an Il-62. At that time, the Central Aero and Hydrodynamics Institute (TsAGI) favoured the clean-winged, rear-engined, T-tailed configuration for airliners. The BAC Three-Eleven and BAC/CASA/MBB Europlane projects had similar configurations. The configuration of heavy jet aircraft was a politically sensitive issue in the USSR. Aircraft designer Leonid Selyakov states this of the underwing-engine US-pioneered layout which gradually became standard for jet airliners: "The configuration of the В-47, taken on strength by the US Air Force ... brought forth a veritable storm of critical opinions from [Soviet] aviation scientists. Responsible TsAGI officials and industry leaders robustly called that aircraft 'utter nonsense' (similar opinions were expressed of the Boeing 747)." Similar controversies were known in Western aeronautical circles but this Soviet approach showed a typical streak of dogmatism which held that problems had immutable, "scientifically correct" solutions. However, not all Soviet aviation engineers were so fixed in their ideas, and the configuration issue figured in a meeting held discreetly in Paris in the late 1960s between Boeing engineers (including Joe Sutter, chief project engineer for the 747, and Bob Withington, a senior engineer who was deeply involved in the SST program) and some of their Soviet counterparts.
membrane A supramolecular aggregate of amphipathic lipid molecules which when suspended in a polar solvent tend to arrange themselves into structures which minimize the exposure of their hydrophobic tails by sheltering them within a ball created by their own hydrophilic heads (i.e. a micelle). Certain types of lipids, specifically phospholipids and other membrane lipids, commonly occur as double-layered sheets of molecules when immersed in an aqueous environment, which can themselves assume approximately spherical shapes, acting as semipermeable barriers surrounding a water-filled interior space. This is the basic structure of the biological membranes enclosing all cells, vesicles, and membrane-bound organelles.
Drugs active in microgram range, most notably LSD, are commonly distributed illicitly on blotting paper. A liquid solution of the drug is applied to the blotting paper, which commonly is perforated into individual doses and artfully decorated with what is known as blotter art. Vanity blotter is blotter art that has not been exposed to LSD and is usually sold as a collectible, although inevitably much of this art ends up in illegal distribution. The artwork is printed onto blotter paper and then sometimes perforated into tiny squares or "tabs" which can be torn or cut apart. Most blotter art designs have grid lines as part of the design to either aid in perforation or to be left as a cutting grid. Blotter as a drug delivery method allows for easy dosing of potent substances, and easy sublingual administration of drugs which has made it increasingly popular as a preparation for other potent drugs, including 25I-NBOMe and alprazolam. Plain white LSD blotter without artwork is commonly referred to as “WoW” (White on White) and is usually not perforated but rather gridded with a pen and sometimes laid on common watercolour paper.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
It is a synthetic peptide built from 44 amino acids arranged in the same order as human growth hormone-releasing hormone. A short fatty-acid chain, described as a trans-3-hexenoyl group, is attached to the first amino acid. The finished molecule is formulated as a sterile powder that is dissolved before use.